Rates and Patterns of Clonal Oncogenic Mutations in the Normal Human Brain

Javier Ganz1,2,3,4,5, Eduardo A Maury1,2,3,4,5,6, Basheer Becerra1,2,3,4,5

  • 1Division of Genetics and Genomics, Manton Center for Orphan Disease, Boston Children's Hospital, Boston, Massachusetts.

Cancer Discovery
|August 14, 2021
PubMed

Insights

Oncogenic mutations, including IDH1, were found in 5.4% of non-diseased human brains, particularly in white matter and glial cells. These brain mutations were less common in older individuals, offering insights into early brain tumor development.

Area of Science:

  • Neuroscience
  • Genetics
  • Oncology

Background:

  • Oncogenic mutations are known in non-neural tissues but their prevalence in the human brain is unclear.
  • Understanding these mutations is crucial for deciphering brain tumor origins.

Purpose of the Study:

  • To investigate the prevalence and characteristics of oncogenic somatic single-nucleotide variants (sSNVs) in the non-diseased human brain.
  • To explore the relationship between these mutations, age, and brain cell types.

Main Methods:

  • Targeted sequencing of 418 brain samples from 110 individuals.
  • Analysis of bulk RNA sequencing data from 1,816 non-diseased brain samples.
  • Examination of clonal copy number variants and mutational signatures.

Main Results:

  • Oncogenic sSNVs were detected in 5.4% of brains, including IDH1R132H.
  • Mutations were enriched in subcortical white matter and glial cells.
  • sSNVs were less common in older individuals, with a depletion of high-allele frequency variants.

Conclusions:

  • The normal brain harbors oncogenic mutations that resemble those found in gliomas, suggesting a role in early oncogenesis.
  • These findings provide insights into the origin and early evolution of brain tumors.
  • Establishing mutational baselines in the non-diseased brain is essential for diagnostics.